Thursday 06 October 2022 from 13:00 to 14:10
PO.4 E- POSTER SESSION 4: disease activity measurements, flare and remission, epidemiology, etiology, genetics, epigenetics
PO.4.75 The anti-BDCA2 antibody biib059 improves joint and skin manifestations in patients with SLE and both active arthritis and rash
Share this article
Click the icon of the social media platform on which you would like to share this article.
Email this article to a friend
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.